News | Mammography | October 08, 2018

X-ray Mammography Adoption to Skyrocket for Breast Cancer Detection

Two-dimensional systems offering low radiation dosage to gain traction with the phasing out of traditional systems, finds Frost & Sullivan

X-ray Mammography Adoption to Skyrocket for Breast Cancer Detection

October 8, 2018 — Highly populated countries have traditionally been slow adopters of non-conventional business models, but a new Frost & Sullivan report says government initiatives to promote early tumor detection are expected to drive the use of X-ray mammography imaging solutions in these countries.

China and Eastern European (EE) nations such as Hungary and Poland are poised to be growth hubs for mammography solutions as their governments roll out organized, population-based screening. India and other countries in EE like Romania are still in the development phase. Vendors in these markets are strategically employing leasing, managed equipment services, and a variety of rental and pay-per-use models to boost procedural volumes. Additionally, new business models focusing on workflow efficiency will be the most feasible due to high budget deficits in these markets. At the same time, the evolution of payment models toward outcome-based reimbursement underlines the need for precision diagnosis.

“Although analog and computed radiography (CR) mammography will continue to generate revenues from developing economies over the next three to five years, their increasing obsolescence will present considerable opportunities for 2-D digital radiography (DR) systems,” said Poornima Srinivasan, industry analyst, transformational health with Frost & Sullivan. "Studies show that digital breast tomosynthesis (DBT) is a game-changing technology for screening programs due to its ability to detect tumors in women with dense breast tissue. Similarly, 2-D DR mammography with 3-D DBT enhancement and synthesized 2-D imaging also offer high price-performance value."

Frost & Sullivan’s recent analysis, Global X-ray Mammography Imaging Systems Market, Forecast to 2022, analyzes various market trends such as the utilization of mammography systems, breast care statistics, mammography procedure volume analysis, and clinical layout of breast care. It covers growth indicators, growth strategies, competitive structure, and market share and revenues forecasts for North America, Europe and Asia-Pacific. The product segments covered include analog, computed, 2-D digital, 2-D digital to DBT upgrade, and digital breast tomosynthesis.

"To further improve product uptake, vendors are positioning 3-D with multimodality views, setting up workstations with 2-D and 3-D comparisons, and creating advanced detectors and algorithms to detect breast cancer at an early stage," noted Srinivasan. "Significantly, they are also launching technologies such as contrast-enhanced spectral mammography, which provides low-energy 2-D mammographic imaging on par with magnetic resonance imaging (MRI).”

Overall, the report indicates that vendors looking to expand their footprint in this market and monetize growth opportunities need to:

  • Offer value-adds through additional software services and improve the value proposition for clinical and financial stakeholders;
  • Realign care models to focus on painless patient comfort systems that standardize compression pressure with minimum radiation dose;
  • Deliver a fully integrated solution that provides access to medical imaging data as telemammography consultation gains currency;
  • Introduce technologies focusing on microcalcifications and breast density assessment; and
  • Collaborate with radiographers, medical physicists and radiologists.

With technology developments in dose reduction, optimization, specificity, and sensitivity for early tumor detection, mammography will continue to be the preferred imaging tool for breast cancer detection.

For more information: ww2.frost.com

Related Content

Joseph J. Cappello Named Executive Director of Are You Dense Nonprofits
News | Breast Density | February 20, 2019
The boards of Are You Dense Inc. and Are You Dense Advocacy Inc., founded by the late Nancy M. Cappello, Ph.D.,...
Congress Directs FDA to Establish Federal Breast Density Inform Standard
News | Breast Density | February 19, 2019 | Jeff Zagoudis, Associate Editor
As part of a federal spending bill passed late Friday, Congress directed the U.S. Food and Drug Administration (FDA) to...
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Hologic Launches Unifi Analytics Business Intelligence Tool
Technology | Analytics Software | February 12, 2019
Hologic Inc. announced the U.S. launch of Unifi Analytics, a business intelligence tool that allows healthcare...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City
News | Mammography | February 11, 2019
Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast...
breast density cancer awareness
News | Breast Density | February 08, 2019
Governor Michelle Lujan Grisham has signed breast density inform bill, ...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Oxford University Hospitals Employs Barco Synergi for Multi-disciplinary Cancer Conferences
News | Oncology Diagnostics | February 06, 2019
Oxford University Hospitals (OUH) is trialing clinical collaboration technology from Barco for its Multi-disciplinary...